A Study of Gemcitabine and Carboplatin (Plus Herceptin in Human Epidermal Growth Factor Receptor 2 Positive [HER2+] Patients) With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Herceptin
Related studies linked through entity extraction aliases.
Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Preoperative Herceptin and Navelbine for Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fulvestrant and/or Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Herceptin in Patients With Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas
- Status
- COMPLETED
- Phase
- PHASE2
Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
- Status
- COMPLETED
- Phase
- PHASE3